Formulation And Evaluation Of Garlic Powder Loaded Floating Matrix Tablet

Objective: The objective of the present work was to formulate and evaluate a stable, odour free garlic powder loaded floating matrix tablet for the treatment of peptic ulcers. Methods: A gastro-retentive floating matrix tablet (FMT) formulation of garlic powder (GP) was prepared using various concentrations of hydroxypropyl methylcellulose K4M (HPMC K4 M) and effervescent system (sodium bicarbonate and citric acid in 1:1 % w/w) to achieve desirable floating time (FT), floating lag time (FLT) and drug release. Wet granulation method was selected using ethanol as a binder for preparation of tablet. 32 full factorial designs were used for selection of suitable polymer concentration and effervescent system. Nonenteric film coating was applied to mask GP odour. Results: It was observed that FMT with optimum quantities of HPMC K4M and the effervescent system showed 97 % of drug release in 12 h with FT up to 10 h and minimum FLT of 3 min. There was no significant change in FLT, FT and drug content during the stability study of FMT. Conclusion: A stable, sustained release FMT of GP tablets using HPMC K4M and an effervescent system was successfully prepared. This formulation can overcome problems of taste and odour masking, gastric irritation, and loss of active constituents present in garlic.

Estimation Of Bacoside-A In Bacopa Monnieri Aerial Parts Using Tlc Densitometry

Objective: The objective of the present work was to formulate and evaluate a stable, odour free garlic powder loaded floating matrix tablet for the treatment of peptic ulcers. Methods: A gastro-retentive floating matrix tablet (FMT) formulation of garlic powder (GP) was prepared using various concentrations of hydroxypropyl methylcellulose K4M (HPMC K4 M) and effervescent system (sodium bicarbonate and citric acid in 1:1 % w/w) to achieve desirable floating time (FT), floating lag time (FLT) and drug release. Wet granulation method was selected using ethanol as a binder for preparation of tablet. 32 full factorial designs were used for selection of suitable polymer concentration and effervescent system. Nonenteric film coating was applied to mask GP odour. Results: It was observed that FMT with optimum quantities of HPMC K4M and the effervescent system showed 97 % of drug release in 12 h with FT up to 10 h and minimum FLT of 3 min. There was no significant change in FLT, FT and drug content during the stability study of FMT. Conclusion: A stable, sustained release FMT of GP tablets using HPMC K4M and an effervescent system was successfully prepared. This formulation can overcome problems of taste and odour masking, gastric irritation, and loss of active constituents present in garlic.

Cinética de fermentação ruminal in vitro de silagens de híbridos de sorgo / Ruminal fermentation kinetics of sorghum hybrid silages

Objetivou-se com esta pesquisa avaliar as silagens de 23 híbridos de sorgo por meio da técnica in vitro semiautomática de produção de gases. Foi utilizado o delineamento inteiramente ao acaso, com 23 tratamentos e três repetições, sendo os tratamentos as silagens de híbridos de sorgo. Os híbridos foram cultivados na estação experimental do Instituto Nacional do Semiárido (INSA), no município de Campina Grande - PB. A produção de gases foi estimada por intermédio do modelo logístico bicompartimental, ajustado às curvas de produção cumulativa de gases. Com relação ao volume final de carboidratos fibrosos (VfCF), houve efeito de híbrido (P<0,05), com resultados variando de 105,99 a 144,53mL/g de MS. Os valores de taxa de degradação dos carboidratos fibrosos (KdCF) variaram (P<0,05), e o híbrido 866041 apresentou o maior resultado 0,015h-1. Os valores de volume final total (VfT) variaram (P<0,05), e os híbridos 870085, Volumax e XBS 60329 apresentaram maiores (P<0,05) valores de VfT em relação aos demais. Pela análise multivariada, foram formados seis grupos distintos. O grupo 2, composto pelos híbridos 22 (Volumax) e 23 (XBS60329), apresentou os maiores valores médios para os volumes de gás, tanto para os carboidratos fibrosos quanto para os não fibrosos. O grupo 4, composto pelo híbrido 1 (866005), apresentou as menores médias para volume de gás produzido e o maior lag time (3,15 horas). Todos os híbridos estudados apresentam potencial para ensilagem, de acordo com a cinética de fermentação ruminal...

The aim of this research was to evaluate the silage of 23 sorghum hybrids using the in vitro semi-automatic gas production technique. A completely randomized design with 23 treatments was used, with three replications, and treatments were the sorghum-hybrids silages. Hybrids were grown at the experimental station of the Instituto Nacional do Semiárido (INSA), in Campina Grande - PB. The gas production was estimated using the bicompartimental logistic model, adjusted to the curves of cumulative gas production. A significant effect (P<0.05) was observed for final gas of fibrous carbohydrates (VfCF), which results ranged from 105.99 to 144.53mL/g of DM. Degradation rate of fibrous carbohydrates (KdCF) values ranged (P<0.05) for the hybrid 866041, which showed the highest result 0.015h-1. Final total volume (VFT) was affected by hybrid (P<0.05), in which hybrids 870085, Volumax and XBS60329 had the highest (P<0.05) values compared to other hybrids. By multivariate analysis were formed six distinct groups. Group 2, consisting of hybrids 22 (Volumax) and 23 (XBS60329) showed the highest average values for gas volumes, both for fibrous carbohydrates and for the non-fibrous. Group 4, comprising the hybrid 1 (866005), had the lowest gas volume produced means and a highest lag time (3.15 hours). All hybrids studied have potential to silage, according to the ruminal fermentation kinetics...

Development and evaluation of nifidipine loaded tablet formulation for colon drug delivery.

Pulsatile release profile is characterized by a lag time followed by rapid and complete drug release. Pulsatile drug delivery systems are classified into time-controlled and site-specific delivery systems. The lag time is taken as the time of less than 10% drug release. The objective of present study was to develop a pulsatile compression coated tablet. The system was developed into two steps i.e. firstly core tablet was prepared containing Nifidipine; secondly core tablet was coated with polymer blend of ethyl cellulose (water insoluble polymer) and Eudragit L 100 (Enteric polymer). From the study it was concluded that the formulation having a coating level of 50% w/w of core and weight ratio of ethyl cellulose to Eudragit L 100 (20%) showed lesser release profile as compared to other formulation i.e. 52.83% in 12hrs. As we increase the weight ratio of ethyl cellulose to Eudragit L 100 better entrapment of drug leading to controlled release of drug.

Estímulo iatrotrópico y tiempo al diagnóstico en pacientes pediátricos con leucemia linfoblástica aguda / Iatrotropic stimulus and lag time for pediatric patients with acute lymphoblastic leukemia

Introducción. La leucemia linfoblástica aguda (LLA) es una enfermedad potencialmente curable en la que el éxito del tratamiento depende de la detección oportuna de la enfermedad; por lo anterior, resulta relevante identificar los factores que influyen en el periodo previo al diagnóstico. El objetivo de este estudio es describir el intervalo entre el inicio de los síntomas atribuibles a la enfermedad y la confirmación diagnóstica, en términos del tiempo transcurrido (lag-time), del estímulo iatrotrópico y de la atención médica recibida, así como estimar la asociación de estos factores con la mortalidad. Métodos. Se revisaron los expedientes clínicos de 182 pacientes pediátricos con LLA en 9 centros de atención oncológica en la República Mexicana y se realizaron entrevistas a sus familiares para reconstruir el periodo previo al diagnóstico. Resultados. Se incluyeron 99 pacientes vivos y 83 que fallecieron, con una media de edad de 7.3 ± 4.7 años. El promedio de tiempo entre el inicio de los síntomas y el diagnóstico fue de 43.5 ± 22.5 días y acudieron a un promedio de 2.3 consultas antes de la confirmación diagnóstica. Los principales motivos para solicitar la atención médica fueron: astenia y adinamia (47.4%), fiebre (44.8%), palidez (44.3%), hiporexia/anorexia (20.9%) y cefalea (19.9%). El número de médicos especialistas no oncólogos consultados y de consultas previas al diagnóstico resultaron factores protectores para la mortalidad (OR 0.77 y 0.64, respectivamente). Conclusiones. El tiempo de espera entre el inicio de los síntomas y la confirmación diagnóstica es mayor al reportado en países desarrollados; esto se debe, principalmente, a la atención médica recibida. El número de médicos y de consultas previas resultaron factores protectores para mortalidad, probablemente como consecuencia de la detección oportuna y la vigilancia médica de los síntomas inespecíficos que orientan a la presencia de la enfermedad.

Background. Acute lymphoblastic leukemia (ALL) is a potentially curable disease where success of the treatment depends on the timely detection of the disease; therefore, it is important to identify those influencing factors during the prediagnostic period. The objective of this study was to describe the interval time from onset of symptoms attributable to the disease to the diagnostic confirmation in terms of elapsed time (lag-time), iatrotropic stimulus and received medical care, as well as to estimate the association of these factors with mortality. Methods. We reviewed 182 clinical files from pediatric patients with ALL in nine cancer treatment centers in Mexico and conducted interviews with their families to rebuild the run-up time until diagnosis. Results. We included 99 living patients and 83 patients who died; average age of the patients was 7.3 ± 4.7 years. The average time between symptom onset and diagnosis was 43.5 ± 22.5 days. Patients had an average of 2.3 consultations prior to diagnostic confirmation. The main reasons for requesting medical attention were asthenia and adynamia (47.4%), fever (44.8%), pallor (44.3%), hyperoxia/anorexia (20.9%) and headache (19.9%). The number of non-oncological physicians surveyed and number of consultations until diagnosis were protective factors for mortality (OR 0.77 and 0.64, respectively). Conclusions. Time between symptom onset and diagnostic confirmation is longer than what has been reported in developed countries mainly due to medical attention received. The number of physicians and number of prior consultations were protective factors for mortality, probably as a result of early detection and medical surveillance of nonspecific symptoms that lead to the presence of the disease.

Development and evaluation of a chronotherapeutic drug delivery system of torsemide / Desenvolvimento e avaliação de um sistema de entrega de drogas cronoterapêuticas de torsemida

The objective of this study was to prepare and evaluate chronotherapeutic drug delivery systems (ChrDDs) of torsemide. Compression coated tablets (CCT) containing torsemide in the core tablet were prepared by the compression coating technique with different grades of polyethylene oxide (PEO WSR 301 & 1105). The optimized formulations were characterised for tabletting parameters and drug polymer interaction by Fourier-Transform Infrared Spectroscopy (FTIR).The hardness of all the CCT using PEO WSR 301 & PEO WSR 1105 were in the range 6-8 kg/cm² & 5.5 to 7 kg/cm² respectively. Their friability values were <0.3 percent. All the CCT showed a clear lag time but finalized as per the predetermined lag time. As the amount of PEO was increased in the outer layer the drug released was delayed. The drug content of all the CCT was >99 percent. The FTIR studies showed no interaction throughout the process of development. Formulations of F7 and of P7 were considered optimized formulations since they yielded a predetermined lag time of 6h before burst release. Hence, these formulations can be exploited to achieve chronotherapeutic drug delivery systems of Torsemide for the treatment of hypertension at the time the patient needs it.

O objetivo deste estudo foi preparar e avaliar sistemas cronoterapêuticos de liberação de fármacos (ChrDDs) de torsemida. Comprimidos revestidos por compressão (CCT) contendo torsemida no (núcleo) foram preparados pela técnica de revestimento por compressão, com diferentes categorias de óxido de polietileno (PEO WSR 301 & 1105). As formulações otimizadas foram caracterizadas por parâmetros de compressão e interação fármaco polímero por Infravermelho com Transformada de Fourier (FTIR). A dureza dos CCT utilizando PEO WSR 301 e PEO WSR 1105 foi entre 6-8 kg/cm² e 5,5 a 7 kg/cm², respectivamente. Os valores de friabilidade foram <0,3 por cento. Todos os CCT mostraram claro tempo de retardo, mas finalizaram de acordo com o tempo de retardo pré-determinado. À medida que a quantidade de PEO aumentava na camada mais externa, a liberação do fármaco era retardada. O teor de fármaco em todos os CCT foi >99 por cento. Os estudos de FTIR mostraram que não h[a interação durante o processo de desenvolvimento. As formulações F7 e P7 foram consideradas otimizadas, uma vez que resultaram em tempo de retardo pré-determinado de 6 h antes da liberação por meio de explosão. Dessa forma, estas formulações podem ser exploradas para se obter sistemas de liberação.

Delay of medical care for symptomatic breast cancer: a literature review: [review] / El retraso en la atención médica del cáncer de mama: una revisión de la literatura: [revisión]

The purpose of this paper is to organize and summarize existing information on delayed medical attention for women with breast cancer and identify research needs in this area. This review is organized in six parts: origins and permanence of the message "do not delay" medical attention for potential cancer symptoms; definition and classification of breast cancer delay; impact of delay on breast cancer prognosis; factors related to breast cancer delay and the ways these have been studied; the study of breast cancer delay in Mexico; and directions for future research in developing countries, with a special focus on Mexico. We point out the need of a more integral study of delay that takes into account socio-structural and health services factors, in order to find modifiable factors towards which political actions should be directed to improve breast cancer medical attention in underdeveloped countries.

El objetivo de esta revisión es integrar información disponible con respecto al retraso en la atención médica del cáncer de mama e identificar necesidades de investigación en este tema. La revisión consta de seis apartados: origen del mensaje "no retrasar" ante la aparición de síntomas de cáncer; definición y clasificación del retraso en la atención del cáncer de mama; impacto del retraso sobre el pronóstico de la enfermedad; factores asociados con el retraso; la investigación del retraso en la atención del cáncer de mama en México; y necesidades de investigación en este tema. Se señala la necesidad de estudiar el retraso en la atención del cáncer de mama de forma más integral, tomando en cuenta características socio-estructurales y de servicios de salud, para identificar factores modificables hacia los cuales dirigir esfuerzos para mejorar la atención de esta enfermedad en países en vías de desarrollo.

Total antioxidants capacity in human plasma: A measurement method and some related experiments

Free radical and antioxidant are very interesting field of research in other country as in Viet Nam. They are mentioned as a new pathogennic agent. Objectives: Determination of total antioxidant capacity in plasma. Methods: Lag-time assay was established to measure Total Antioxidants Capacity (TAC) in human plasma of healthy volunteers (6 males, 4 females, aged 29,8+-5,2). Results: - TAC was 513.3+/-79.64 mM Trolox equivalents. TAC was significantly higher in men (568.83+/-41.08 mM Trolox equivalents) in comparison with women (430.00+/-28.15 mM Trolox equivalents). A main reason was a higher concentration of uric acid in men compared with women (397.5+-79.86 mM versus 245+-33.16 mM). Conclusions: TAC in plasma after drinking vegetable juice for 1 week (547.8+-80.67 mM Trolox equivalents) was significantly higher in comparison with before (513.3+-79.64 mM Trolox equivalents).